Tradestie Institutional Equity Comparison Engine
PACS vs BTSG โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
PACS Overall Edge
PACS Captures Institutional Edge (4โ0 Pillars ยท 8โ2 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to PACS Group, Inc. (PACS) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, PACS trades at 15.3x Forward P/E with 7.4% operating margin (+11.5% YoY revenue) versus BTSG at 25.9x Forward P/E and 3.5% operating margin (+26.4% YoY). In options structure, PACS sits in CONSOLIDATION (11th %ile IV; Dealer Gamma Walls on Pro) against BTSG sits in CONSOLIDATION (100th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
PACS
PACS 15.3x vs BTSG 25.9x Fwd P/E
Growth & Margin Winner
PACS
Op Margin 7.4% vs 3.5% ยท YoY +11.5% vs +26.4%
Momentum & Technical Winner
PACS
1Y +159.5% vs +94.8% ยท 52W Pos 79% vs 74%
Options & Structure Winner
PACS
CONSOLIDATION (11th %ile IV) vs CONSOLIDATION (100th %ile IV)
PACS
NYSE
PACS Group, Inc.
Services-Skilled Nursing Care Facilities
$43.67
+1.49% 1D
Market Cap
$6.8B
1M Return
-8.06%
1Y Return
+159.48%
Forward P/E
15.3x
Unified AI Score
46.8 / 100
HOLD
Tech 35.0
Fund 48.0
Flow 62.0
Mom 50.0
BTSG
NASDAQ
BrightSpring Health Services, Inc. Common Stock
Services-Home Health Care Services
$62.84
-1.84% 1D
Market Cap
$12.7B
1M Return
+3.25%
1Y Return
+94.79%
Forward P/E
25.9x
Unified AI Score
42.6 / 100
HOLD
Tech 20.0
Fund 40.0
Flow 57.0
Mom 50.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
PACS +159.48%
BTSG +94.79%
Spread: +64.69 pp (PACS Lead)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | PACS Revenue | BTSG Revenue | PACS Op. Margin | BTSG Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2022 | $2.40B | $7.72B | 9.6% | 2.4% | PACS |
| FY2023 | $3.11B | $7.69B | 6.7% | 0.8% | PACS |
| FY2024 | $4.09B | $10.1B | 3.0% | 1.1% | PACS |
| FY2025 | $5.29B | $12.9B | 5.9% | 2.3% | PACS |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | PACS | BTSG | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $6.8B | $12.7B | Larger Scale | BTSG |
| Trailing P/E Ratio Valuation | 26.2x | 45.4x | Lower Multiple | PACS |
| Forward P/E Ratio Valuation | 15.3x | 25.9x | Lower Multiple | PACS |
| Revenue Growth (YoY) Growth | +11.5% | +26.4% | Higher Growth | BTSG |
| Operating Margin (TTM) Profitability | 7.4% | 3.5% | Higher Margin | PACS |
| Net Profit Margin Profitability | 4.9% | 2.7% | Higher Margin | PACS |
| Return on Equity (ROE) Capital Efficiency | 26.5% | 15.5% | Higher ROE | PACS |
| 52-Week Range Position Momentum | 79% ($14โ$52) | 74% ($31โ$74) | Stronger Trend | PACS |
| Beta / 30D Volatility Risk Regime | 0.78ฮฒ ยท 51% Vol | 0.94ฮฒ ยท 59% Vol | Lower Realized Risk | PACS |
| Unified Institutional Score Composite Signal | 46.8 / 100 (HOLD) | 42.6 / 100 (HOLD) | Higher Composite | PACS |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full PACS vs BTSG Buy Guide
PACS
CONSOLIDATION
83d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
11th %ile
IV Regime
Compressed (<25th %ile)
BTSG
CONSOLIDATION
104d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
100th %ile
IV Regime
Extreme (>80th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither PACS nor BTSG registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.